APO Research
Talk to an analyst

APO RESEARCH · REPORT

Chronic Gastritis Treatment

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Chronic Gastritis Treatment Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

19 December 2025197 pages

Choose your research edition.

Industry ResearchChronic Gastritis Treatment Industry Research Report 2026116 pages · $2,950 USDIndustry Growth & TrendsGlobal Chronic Gastritis Treatment Industry Growth and Trends Forecast to 2032102 pages · $3,450 USDMarket StructureGlobal Chronic Gastritis Treatment Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032197 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Chronic Gastritis Treatment Market Outlook and Growth Opportunities 2026193 pages · $4,250 USDMarket Analysis & ForecastGlobal Chronic Gastritis Treatment Market Analysis and Forecast 2026-2032193 pages · $4,950 USD

Market perspective

The global Chronic Gastritis Treatment market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The US & Canada market for Chronic Gastritis Treatment is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Chronic Gastritis Treatment is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Chronic Gastritis Treatment is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Chronic Gastritis Treatment is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Chronic Gastritis Treatment include Alchem International, Cipla, Katsura Chemical, Lupin Ltd, Microbiotix, Perrigo Pharmaceutical, RESONANCE LABORATORIES, ROLABO OUTSOURCING and SAURAV CHEMICALS, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Includes

This report provides an overview of the global Chronic Gastritis Treatment market and its size, analyzing global market trends based on historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Chronic Gastritis Treatment and revenue in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Chronic Gastritis Treatment revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering revenue and growth rates—for 2021-2032, and evaluates and forecasts the Chronic Gastritis Treatment market size, projected growth trends, production technologies, key applications, and end-use industries.

Chronic Gastritis Treatment Segment by Company

Alchem International

Cipla

Katsura Chemical

Lupin Ltd

Microbiotix

Perrigo Pharmaceutical

RESONANCE LABORATORIES

ROLABO OUTSOURCING

SAURAV CHEMICALS

AstraZeneca

Hangzhou Vega

Wuhan Senwayer Century

Chronic Gastritis Treatment Segment by Type

H2 Antagonists

Antacids

Proton Pump Inhibitors

Others

Chronic Gastritis Treatment Segment by Application

Drug Stimulate

Stress

Irritant

Virus Infection

Others

Chronic Gastritis Treatment Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Colombia

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Chronic Gastritis Treatment market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Chronic Gastritis Treatment and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Chronic Gastritis Treatment.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. Revenue of Chronic Gastritis Treatment in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Chronic Gastritis Treatment industry.

Chapter 3: Detailed analysis of Chronic Gastritis Treatment companies' competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Chronic Gastritis Treatmentrevenue, gross margin, and recent development, etc.

Chapter 7: North America (US & Canada) by type, by application and by country, revenue for each segment.

Chapter 8: Europe by type, by application and by country, revenue for each segment.

Chapter 9: China by type, and by application, revenue for each segment.

Chapter 10: Asia (excluding China) by type, by application and by region, revenue for each segment.

Chapter 11: South America, Middle East & Africa by type, by application and by country, revenue for each segment.

Chapter 12: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Chronic Gastritis Treatment Market Size Growth Rate by Type (US$ Million): 2021 VS 2025 VS 2032 Table 2. Key Players of H2 Antagonists Table 3. Key Players of Antacids Table 4. Key Players of Proton Pump Inhibitors Table 3. Key Players of Others Table 4. Global Chronic Gastritis Treatment Market Size Growth Rate by Application (US$ Million): 2021 VS 2025 VS 2032 Table 5. Key Players of Drug Stimulate Table 6. Key Players of Stress Table 7. Key Players of Irritant Table 8. Key Players of Virus Infection Table 9. Key Players of Others Table 10. Global Chronic Gastritis Treatment Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 11. Global Chronic Gastritis Treatment Market Size by Region (2021-2026) & (US$ Million) Table 12. Global Chronic Gastritis Treatment Market Share by Region (2021-2026) Table 13. Global Chronic Gastritis Treatment Market Size by Region (2027-2032) & (US$ Million) Table 14. Global Chronic Gastritis Treatment Market Share by Region (2027-2032) Table 15. Chronic Gastritis Treatment Industry Trends Table 16. Chronic Gastritis Treatment Industry Drivers Table 17. Chronic Gastritis Treatment Industry Opportunities and Challenges Table 18. Chronic Gastritis Treatment Industry Restraints Table 19. Global Chronic Gastritis Treatment Revenue by Company (US$ Million) & (2021-2026) Table 20. Global Chronic Gastritis Treatment Revenue Market Share by Company (2021-2026) Table 21. Global Chronic Gastritis Treatment Players Revenue Ranking, 2024 VS 2025 VS 2026 Table 22. Global Chronic Gastritis Treatment Key Company Head Office and Area Served Table 23. Global Chronic Gastritis Treatment Company, Product Type & Application Table 24. Global Chronic Gastritis Treatment Company Establishment Date Table 25. Global Company Market Concentration Ratio (CR5 and HHI) Table 26. Global Chronic Gastritis Treatment by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 27. Global Chronic Gastritis Treatment Market Size by Type 2021 VS 2025 VS 2032 (US$ Million) Table 28. Global Chronic Gastritis Treatment Market Size by Type (2021-2026) & (US$ Million) Table 29. Global Chronic Gastritis Treatment Market Size by Type (2027-2032) & (US$ Million) Table 30. Global Chronic Gastritis Treatment Revenue Market Share by Type (2021-2026) Table 31. Global Chronic Gastritis Treatment Revenue Market Share by Type (2027-2032) Table 32. Global Chronic Gastritis Treatment Market Size by Application 2021 VS 2025 VS 2032 (US$ Million) Table 33. Global Chronic Gastritis Treatment Market Size by Application (2021-2026) & (US$ Million) Table 34. Global Chronic Gastritis Treatment Market Size by Application (2027-2032) & (US$ Million) Table 35. Global Chronic Gastritis Treatment Revenue Market Share by Application (2021-2026) Table 36. Global Chronic Gastritis Treatment Revenue Market Share by Application (2027-2032) Table 37. Alchem International Company Information Table 38. Alchem International Business Overview Table 39. Alchem International Chronic Gastritis Treatment Revenue and Gross Margin (US$ Million) & (2021-2026) Table 40. Alchem International Chronic Gastritis Treatment Product Portfolio Table 41. Alchem International Recent Development Table 42. Cipla Company Information Table 43. Cipla Business Overview Table 44. Cipla Chronic Gastritis Treatment Revenue and Gross Margin (US$ Million) & (2021-2026) Table 45. Cipla Chronic Gastritis Treatment Product Portfolio Table 46. Cipla Recent Development Table 47. Katsura Chemical Company Information Table 48. Katsura Chemical Business Overview Table 49. Katsura Chemical Chronic Gastritis Treatment Revenue and Gross Margin (US$ Million) & (2021-2026) Table 50. Katsura Chemical Chronic Gastritis Treatment Product Portfolio Table 51. Katsura Chemical Recent Development Table 52. Lupin Ltd Company Information Table 53. Lupin Ltd Business Overview Table 54. Lupin Ltd Chronic Gastritis Treatment Revenue and Gross Margin (US$ Million) & (2021-2026) Table 55. Lupin Ltd Chronic Gastritis Treatment Product Portfolio Table 56. Lupin Ltd Recent Development Table 57. Microbiotix Company Information Table 58. Microbiotix Business Overview Table 59. Microbiotix Chronic Gastritis Treatment Revenue and Gross Margin (US$ Million) & (2021-2026) Table 60. Microbiotix Chronic Gastritis Treatment Product Portfolio Table 61. Microbiotix Recent Development Table 62. Perrigo Pharmaceutical Company Information Table 63. Perrigo Pharmaceutical Business Overview Table 64. Perrigo Pharmaceutical Chronic Gastritis Treatment Revenue and Gross Margin (US$ Million) & (2021-2026) Table 65. Perrigo Pharmaceutical Chronic Gastritis Treatment Product Portfolio Table 66. Perrigo Pharmaceutical Recent Development Table 67. RESONANCE LABORATORIES Company Information Table 68. RESONANCE LABORATORIES Business Overview Table 69. RESONANCE LABORATORIES Chronic Gastritis Treatment Revenue and Gross Margin (US$ Million) & (2021-2026) Table 70. RESONANCE LABORATORIES Chronic Gastritis Treatment Product Portfolio Table 71. RESONANCE LABORATORIES Recent Development Table 72. ROLABO OUTSOURCING Company Information Table 73. ROLABO OUTSOURCING Business Overview Table 74. ROLABO OUTSOURCING Chronic Gastritis Treatment Revenue and Gross Margin (US$ Million) & (2021-2026) Table 75. ROLABO OUTSOURCING Chronic Gastritis Treatment Product Portfolio Table 76. ROLABO OUTSOURCING Recent Development Table 77. SAURAV CHEMICALS Company Information Table 78. SAURAV CHEMICALS Business Overview Table 79. SAURAV CHEMICALS Chronic Gastritis Treatment Revenue and Gross Margin (US$ Million) & (2021-2026) Table 80. SAURAV CHEMICALS Chronic Gastritis Treatment Product Portfolio Table 81. SAURAV CHEMICALS Recent Development Table 82. AstraZeneca Company Information Table 83. AstraZeneca Business Overview Table 84. AstraZeneca Chronic Gastritis Treatment Revenue and Gross Margin (US$ Million) & (2021-2026) Table 85. AstraZeneca Chronic Gastritis Treatment Product Portfolio Table 86. AstraZeneca Recent Development Table 87. Hangzhou Vega Company Information Table 88. Hangzhou Vega Business Overview Table 89. Hangzhou Vega Chronic Gastritis Treatment Revenue and Gross Margin (US$ Million) & (2021-2026) Table 90. Hangzhou Vega Chronic Gastritis Treatment Product Portfolio Table 91. Hangzhou Vega Recent Development Table 92. Wuhan Senwayer Century Company Information Table 93. Wuhan Senwayer Century Business Overview Table 94. Wuhan Senwayer Century Chronic Gastritis Treatment Revenue and Gross Margin (US$ Million) & (2021-2026) Table 95. Wuhan Senwayer Century Chronic Gastritis Treatment Product Portfolio Table 96. Wuhan Senwayer Century Recent Development Table 97. North America Chronic Gastritis Treatment Market Size by Type (2021-2026) & (US$ Million) Table 98. North America Chronic Gastritis Treatment Market Size by Type (2027-2032) & (US$ Million) Table 99. North America Chronic Gastritis Treatment Market Size by Application (2021-2026) & (US$ Million) Table 100. North America Chronic Gastritis Treatment Market Size by Application (2027-2032) & (US$ Million) Table 101. North America Chronic Gastritis Treatment Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 102. North America Chronic Gastritis Treatment Market Size by Country (2021-2026) Table 103. North America Chronic Gastritis Treatment Market Size by Country (2027-2032) Table 104. Europe Chronic Gastritis Treatment Market Size by Type (2021-2026) & (US$ Million) Table 105. Europe Chronic Gastritis Treatment Market Size by Type (2027-2032) & (US$ Million) Table 106. Europe Chronic Gastritis Treatment Market Size by Application (2021-2026) & (US$ Million) Table 107. Europe Chronic Gastritis Treatment Market Size by Application (2027-2032) & (US$ Million) Table 108. Europe Chronic Gastritis Treatment Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 109. Europe Chronic Gastritis Treatment Market Size by Country (2021-2026) Table 110. Europe Chronic Gastritis Treatment Market Size by Country (2027-2032) Table 111. China Chronic Gastritis Treatment Market Size by Type (2021-2026) & (US$ Million) Table 112. China Chronic Gastritis Treatment Market Size by Type (2027-2032) & (US$ Million) Table 113. China Chronic Gastritis Treatment Market Size by Application (2021-2026) & (US$ Million) Table 114. China Chronic Gastritis Treatment Market Size by Application (2027-2032) & (US$ Million) Table 115. Asia Chronic Gastritis Treatment Market Size by Type (2021-2026) & (US$ Million) Table 116. Asia Chronic Gastritis Treatment Market Size by Type (2027-2032) & (US$ Million) Table 117. Asia Chronic Gastritis Treatment Market Size by Application (2021-2026) & (US$ Million) Table 118. Asia Chronic Gastritis Treatment Market Size by Application (2027-2032) & (US$ Million) Table 119. Asia Chronic Gastritis Treatment Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 120. Asia Chronic Gastritis Treatment Market Size by Country (2021-2026) Table 121. Asia Chronic Gastritis Treatment Market Size by Country (2027-2032) Table 122. South America, Middle East & Africa Chronic Gastritis Treatment Market Size by Type (2021-2026) & (US$ Million) Table 123. South America, Middle East & Africa Chronic Gastritis Treatment Market Size by Type (2027-2032) & (US$ Million) Table 124. South America, Middle East & Africa Chronic Gastritis Treatment Market Size by Application (2021-2026) & (US$ Million) Table 125. South America, Middle East & Africa Chronic Gastritis Treatment Market Size by Application (2027-2032) & (US$ Million) Table 126. South America, Middle East & Africa Chronic Gastritis Treatment Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 127. South America, Middle East & Africa Chronic Gastritis Treatment Market Size by Country (2021-2026) Table 128. South America, Middle East & Africa Chronic Gastritis Treatment Market Size by Country (2027-2032) Table 129. Research Programs/Design for This Report Table 130. Authors List of This Report Table 131. Secondary Sources Table 132. Primary Sources List of Figures Figure 1. Chronic Gastritis Treatment Product Image Figure 2. Global Chronic Gastritis Treatment Market Size Growth Rate by Type, 2021 VS 2025 VS 2032 (US$ Million) Figure 3. Global Chronic Gastritis Treatment Market Share by Type: 2025 VS 2032 Figure 4. H2 Antagonists Image Figure 5. Antacids Image Figure 6. Proton Pump Inhibitors Image Figure 7. Others Image Figure 8. Global Chronic Gastritis Treatment Market Size Growth Rate by Application, 2021 VS 2025 VS 2032 (US$ Million) Figure 9. Global Chronic Gastritis Treatment Market Share by Application: 2025 VS 2032 Figure 10. Drug Stimulate Image Figure 11. Stress Image Figure 12. Irritant Image Figure 13. Virus Infection Image Figure 14. Others Image Figure 15. Global Chronic Gastritis Treatment Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 16. Global Chronic Gastritis Treatment Market Size (2021-2032) & (US$ Million) Figure 17. Global Chronic Gastritis Treatment Market Share by Region: 2025 VS 2032 Figure 18. Years Considered Figure 19. Global Chronic Gastritis Treatment Market Share by Players in 2025 Figure 20. Global Top 5 and 10 Chronic Gastritis Treatment Players Market Share by Revenue in 2025 Figure 21. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 22. Global Chronic Gastritis Treatment Market Size by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 23. Global Chronic Gastritis Treatment Revenue Market Share by Type (2021-2032) Figure 24. Global Chronic Gastritis Treatment Market Size by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 25. Global Chronic Gastritis Treatment Revenue Market Share by Application (2021-2032) Figure 26. North America Chronic Gastritis Treatment Market Size (2021-2032) & (US$ Million) Figure 27. North America Chronic Gastritis Treatment Market Share by Type (2021-2032) Figure 28. North America Chronic Gastritis Treatment Market Share by Application (2021-2032) Figure 29. North America Chronic Gastritis Treatment Market Share by Country (2021-2032) Figure 30. United States Chronic Gastritis Treatment Market Size (2021-2032) & (US$ Million) Figure 31. Canada Chronic Gastritis Treatment Market Size (2021-2032) & (US$ Million) Figure 32. Mexico Chronic Gastritis Treatment Market Size (2021-2032) & (US$ Million) Figure 33. Europe Chronic Gastritis Treatment Market Size (2021-2032) & (US$ Million) Figure 34. Europe Chronic Gastritis Treatment Market Share by Type (2021-2032) Figure 35. Europe Chronic Gastritis Treatment Market Share by Application (2021-2032) Figure 36. Europe Chronic Gastritis Treatment Market Share by Country (2021-2032) Figure 37. Germany Chronic Gastritis Treatment Market Size (2021-2032) & (US$ Million) Figure 38. France Chronic Gastritis Treatment Market Size (2021-2032) & (US$ Million) Figure 39. U.K. Chronic Gastritis Treatment Market Size (2021-2032) & (US$ Million) Figure 40. Italy Chronic Gastritis Treatment Market Size (2021-2032) & (US$ Million) Figure 41. Russia Chronic Gastritis Treatment Market Size (2021-2032) & (US$ Million) Figure 42. Nordic Countries Chronic Gastritis Treatment Market Size (2021-2032) & (US$ Million) Figure 43. China Chronic Gastritis Treatment Market Size (2021-2032) & (US$ Million) Figure 44. China Chronic Gastritis Treatment Market Share by Type (2021-2032) Figure 45. China Chronic Gastritis Treatment Market Share by Application (2021-2032) Figure 46. Asia Chronic Gastritis Treatment Market Size (2021-2032) & (US$ Million) Figure 47. Asia Chronic Gastritis Treatment Market Share by Type (2021-2032) Figure 48. Asia Chronic Gastritis Treatment Market Share by Application (2021-2032) Figure 49. Asia Chronic Gastritis Treatment Market Share by Country (2021-2032) Figure 50. Japan Chronic Gastritis Treatment Market Size (2021-2032) & (US$ Million) Figure 51. South Korea Chronic Gastritis Treatment Market Size (2021-2032) & (US$ Million) Figure 52. Taiwan Chronic Gastritis Treatment Market Size (2021-2032) & (US$ Million) Figure 53. Southeast Asia Chronic Gastritis Treatment Market Size (2021-2032) & (US$ Million) Figure 54. India Chronic Gastritis Treatment Market Size (2021-2032) & (US$ Million) Figure 55. Australia Chronic Gastritis Treatment Market Size (2021-2032) & (US$ Million) Figure 56. South America, Middle East & Africa Chronic Gastritis Treatment Market Size (2021-2032) & (US$ Million) Figure 57. South America, Middle East & Africa Chronic Gastritis Treatment Market Share by Type (2021-2032) Figure 58. South America, Middle East & Africa Chronic Gastritis Treatment Market Share by Application (2021-2032) Figure 59. South America, Middle East & Africa Chronic Gastritis Treatment Market Share by Country (2021-2032) Figure 60. Brazil Chronic Gastritis Treatment Market Size (2021-2032) & (US$ Million) Figure 61. South Africa Chronic Gastritis Treatment Market Size (2021-2032) & (US$ Million) Figure 62. Saudi Arabia Chronic Gastritis Treatment Market Size (2021-2032) & (US$ Million) Figure 63. Turkey Chronic Gastritis Treatment Market Size (2021-2032) & (US$ Million) Figure 64. Argentina Chronic Gastritis Treatment Market Size (2021-2032) & (US$ Million) Figure 65. UAE Chronic Gastritis Treatment Market Size (2021-2032) & (US$ Million) Figure 66. Egypt Chronic Gastritis Treatment Market Size (2021-2032) & (US$ Million) Figure 67. Chile Chronic Gastritis Treatment Market Size (2021-2032) & (US$ Million) Figure 68. Research Process Figure 69. Key Executives Interviewed

Scope & coverage.

Types
  • H2 Antagonists
  • Antacids
  • Proton Pump Inhibitors
  • Others
Applications
  • Drug Stimulate
  • Stress
  • Irritant
  • Virus Infection
  • Others
Companies covered
  • Alchem International
  • Cipla
  • Katsura Chemical
  • Lupin Ltd
  • Microbiotix
  • Perrigo Pharmaceutical
  • RESONANCE LABORATORIES
  • ROLABO OUTSOURCING
  • SAURAV CHEMICALS
  • AstraZeneca
  • Hangzhou Vega
  • Wuhan Senwayer Century

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Market Analysis by Type
  3. 1.2.1 Global Chronic Gastritis Treatment Market Size Growth Rate by Type: 2021 VS 2025 VS 2032
  4. 1.2.2 H2 Antagonists
  5. 1.2.3 Antacids
  6. 1.2.4 Proton Pump Inhibitors
  7. 1.2.5 Others
  8. 1.3 Market Analysis by Application
  9. 1.3.1 Global Chronic Gastritis Treatment Market Size Growth Rate by Application: 2021 VS 2025 VS 2032
  10. 1.3.2 Drug Stimulate
  11. 1.3.3 Stress
  12. 1.3.4 Irritant
  13. 1.3.5 Virus Infection
  14. 1.3.6 Others
  15. 1.4 Global Market Growth Prospects
  16. 1.5 Global Chronic Gastritis Treatment Growth Trends by Region
  17. 1.5.1 Global Chronic Gastritis Treatment Market Size by Region: 2021 VS 2025 VS 2032
  18. 1.5.2 Chronic Gastritis Treatment Market Size by Region (2021-2026)
  19. 1.5.3 Chronic Gastritis Treatment Market Size by Region (2027-2032)
  20. 1.6 Assumptions and Limitations
  21. 1.7 Study Goals and Objectives
  22. 1.8 Years Considered
2 Global Chronic Gastritis Treatment Market Dynamics
  1. 2.1 Chronic Gastritis Treatment Industry Trends
  2. 2.2 Chronic Gastritis Treatment Industry Drivers
  3. 2.3 Chronic Gastritis Treatment Industry Opportunities and Challenges
  4. 2.4 Chronic Gastritis Treatment Industry Restraints
3 Competitive Landscape by Company
  1. 3.1 Global Chronic Gastritis Treatment Revenue by Company (2021-2026)
  2. 3.2 Global Chronic Gastritis Treatment Players Revenue Ranking, 2024 VS 2025 VS 2026
  3. 3.3 Global Chronic Gastritis Treatment Key Company Head office and Area Served
  4. 3.4 Global Chronic Gastritis Treatment Company, Product Type & Application
  5. 3.5 Global Chronic Gastritis Treatment Company Establishment Date
  6. 3.6 Market Competitive Analysis
  7. 3.6.1 Global Chronic Gastritis Treatment Market CR5 and HHI
  8. 3.6.2 Global Top 5 and 10 Chronic Gastritis Treatment Players Market Share by Revenue in 2025
  9. 3.6.3 2025 Chronic Gastritis Treatment Tier 1, Tier 2, and Tier 3
4 Chronic Gastritis Treatment Market by Type
  1. 4.1 Global Chronic Gastritis Treatment Market Size by Type (2021 VS 2025 VS 2032)
  2. 4.2 Global Chronic Gastritis Treatment Market Size by Type (2021-2032)
  3. 4.3 Global Chronic Gastritis Treatment Market Size Share by Type (2021-2032)
5 Chronic Gastritis Treatment Market by Application
  1. 5.1 Global Chronic Gastritis Treatment Market Size by Application (2021 VS 2025 VS 2032)
  2. 5.2 Global Chronic Gastritis Treatment Market Size by Application (2021-2032)
  3. 5.3 Global Chronic Gastritis Treatment Market Size Share by Application (2021-2032)
6 Company Profiles
  1. 6.1 Alchem International
  2. 6.1.1 Alchem International Company Information
  3. 6.1.2 Alchem International Business Overview
  4. 6.1.3 Alchem International Chronic Gastritis Treatment Revenue and Gross Margin (US$ Million) & (2021-2026)
  5. 6.1.4 Alchem International Chronic Gastritis Treatment Product Portfolio
  6. 6.1.5 Alchem International Recent Developments
  7. 6.2 Cipla
  8. 6.2.1 Cipla Company Information
  9. 6.2.2 Cipla Business Overview
  10. 6.2.3 Cipla Chronic Gastritis Treatment Revenue and Gross Margin (US$ Million) & (2021-2026)
  11. 6.2.4 Cipla Chronic Gastritis Treatment Product Portfolio
  12. 6.2.5 Cipla Recent Developments
  13. 6.3 Katsura Chemical
  14. 6.3.1 Katsura Chemical Company Information
  15. 6.3.2 Katsura Chemical Business Overview
  16. 6.3.3 Katsura Chemical Chronic Gastritis Treatment Revenue and Gross Margin (US$ Million) & (2021-2026)
  17. 6.3.4 Katsura Chemical Chronic Gastritis Treatment Product Portfolio
  18. 6.3.5 Katsura Chemical Recent Developments
  19. 6.4 Lupin Ltd
  20. 6.4.1 Lupin Ltd Company Information
  21. 6.4.2 Lupin Ltd Business Overview
  22. 6.4.3 Lupin Ltd Chronic Gastritis Treatment Revenue and Gross Margin (US$ Million) & (2021-2026)
  23. 6.4.4 Lupin Ltd Chronic Gastritis Treatment Product Portfolio
  24. 6.4.5 Lupin Ltd Recent Developments
  25. 6.5 Microbiotix
  26. 6.5.1 Microbiotix Company Information
  27. 6.5.2 Microbiotix Business Overview
  28. 6.5.3 Microbiotix Chronic Gastritis Treatment Revenue and Gross Margin (US$ Million) & (2021-2026)
  29. 6.5.4 Microbiotix Chronic Gastritis Treatment Product Portfolio
  30. 6.5.5 Microbiotix Recent Developments
  31. 6.6 Perrigo Pharmaceutical
  32. 6.6.1 Perrigo Pharmaceutical Company Information
  33. 6.6.2 Perrigo Pharmaceutical Business Overview
  34. 6.6.3 Perrigo Pharmaceutical Chronic Gastritis Treatment Revenue and Gross Margin (US$ Million) & (2021-2026)
  35. 6.6.4 Perrigo Pharmaceutical Chronic Gastritis Treatment Product Portfolio
  36. 6.6.5 Perrigo Pharmaceutical Recent Developments
  37. 6.7 RESONANCE LABORATORIES
  38. 6.7.1 RESONANCE LABORATORIES Company Information
  39. 6.7.2 RESONANCE LABORATORIES Business Overview
  40. 6.7.3 RESONANCE LABORATORIES Chronic Gastritis Treatment Revenue and Gross Margin (US$ Million) & (2021-2026)
  41. 6.7.4 RESONANCE LABORATORIES Chronic Gastritis Treatment Product Portfolio
  42. 6.7.5 RESONANCE LABORATORIES Recent Developments
  43. 6.8 ROLABO OUTSOURCING
  44. 6.8.1 ROLABO OUTSOURCING Company Information
  45. 6.8.2 ROLABO OUTSOURCING Business Overview
  46. 6.8.3 ROLABO OUTSOURCING Chronic Gastritis Treatment Revenue and Gross Margin (US$ Million) & (2021-2026)
  47. 6.8.4 ROLABO OUTSOURCING Chronic Gastritis Treatment Product Portfolio
  48. 6.8.5 ROLABO OUTSOURCING Recent Developments
  49. 6.9 SAURAV CHEMICALS
  50. 6.9.1 SAURAV CHEMICALS Company Information
  51. 6.9.2 SAURAV CHEMICALS Business Overview
  52. 6.9.3 SAURAV CHEMICALS Chronic Gastritis Treatment Revenue and Gross Margin (US$ Million) & (2021-2026)
  53. 6.9.4 SAURAV CHEMICALS Chronic Gastritis Treatment Product Portfolio
  54. 6.9.5 SAURAV CHEMICALS Recent Developments
  55. 6.10 AstraZeneca
  56. 6.10.1 AstraZeneca Company Information
  57. 6.10.2 AstraZeneca Business Overview
  58. 6.10.3 AstraZeneca Chronic Gastritis Treatment Revenue and Gross Margin (US$ Million) & (2021-2026)
  59. 6.10.4 AstraZeneca Chronic Gastritis Treatment Product Portfolio
  60. 6.10.5 AstraZeneca Recent Developments
  61. 6.11 Hangzhou Vega
  62. 6.11.1 Hangzhou Vega Company Information
  63. 6.11.2 Hangzhou Vega Business Overview
  64. 6.11.3 Hangzhou Vega Chronic Gastritis Treatment Revenue and Gross Margin (US$ Million) & (2021-2026)
  65. 6.11.4 Hangzhou Vega Chronic Gastritis Treatment Product Portfolio
  66. 6.11.5 Hangzhou Vega Recent Developments
  67. 6.12 Wuhan Senwayer Century
  68. 6.12.1 Wuhan Senwayer Century Company Information
  69. 6.12.2 Wuhan Senwayer Century Business Overview
  70. 6.12.3 Wuhan Senwayer Century Chronic Gastritis Treatment Revenue and Gross Margin (US$ Million) & (2021-2026)
  71. 6.12.4 Wuhan Senwayer Century Chronic Gastritis Treatment Product Portfolio
  72. 6.12.5 Wuhan Senwayer Century Recent Developments
7 North America
  1. 7.1 North America Chronic Gastritis Treatment Market Size (2021-2032)
  2. 7.2 North America Chronic Gastritis Treatment Market Size by Type
  3. 7.2.1 North America Chronic Gastritis Treatment Market Size by Type (2021-2026)
  4. 7.2.2 North America Chronic Gastritis Treatment Market Size by Type (2027-2032)
  5. 7.2.3 North America Chronic Gastritis Treatment Market Share by Type (2021-2032)
  6. 7.3 North America Chronic Gastritis Treatment Market Size by Application
  7. 7.3.1 North America Chronic Gastritis Treatment Market Size by Application (2021-2026)
  8. 7.3.2 North America Chronic Gastritis Treatment Market Size by Application (2027-2032)
  9. 7.3.3 North America Chronic Gastritis Treatment Market Share by Application (2021-2032)
  10. 7.4 North America Chronic Gastritis Treatment Market Size by Country
  11. 7.4.1 North America Chronic Gastritis Treatment Market Size by Country (2021 VS 2025 VS 2032)
  12. 7.4.2 North America Chronic Gastritis Treatment Market Size by Country (2021-2026)
  13. 7.4.3 North America Chronic Gastritis Treatment Market Size by Country (2027-2032)
  14. 7.4.4 North America Chronic Gastritis Treatment Market Share by Country (2021-2032)
  15. 7.4.5 United States
  16. 7.4.6 Canada
  17. 7.4.7 Mexico
8 Europe
  1. 8.1 Europe Chronic Gastritis Treatment Market Size (2021-2032)
  2. 8.2 Europe Chronic Gastritis Treatment Market Size by Type
  3. 8.2.1 Europe Chronic Gastritis Treatment Market Size by Type (2021-2026)
  4. 8.2.2 Europe Chronic Gastritis Treatment Market Size by Type (2027-2032)
  5. 8.2.3 Europe Chronic Gastritis Treatment Market Share by Type (2021-2032)
  6. 8.3 Europe Chronic Gastritis Treatment Market Size by Application
  7. 8.3.1 Europe Chronic Gastritis Treatment Market Size by Application (2021-2026)
  8. 8.3.2 Europe Chronic Gastritis Treatment Market Size by Application (2027-2032)
  9. 8.3.3 Europe Chronic Gastritis Treatment Market Share by Application (2021-2032)
  10. 8.4 Europe Chronic Gastritis Treatment Market Size by Country
  11. 8.4.1 Europe Chronic Gastritis Treatment Market Size by Country (2021 VS 2025 VS 2032)
  12. 8.4.2 Europe Chronic Gastritis Treatment Market Size by Country (2021-2026)
  13. 8.4.3 Europe Chronic Gastritis Treatment Market Size by Country (2027-2032)
  14. 8.4.4 Europe Chronic Gastritis Treatment Market Share by Country (2021-2032)
  15. 8.4.5 Germany
  16. 8.4.6 France
  17. 8.4.7 U.K.
  18. 8.4.8 Italy
  19. 8.4.9 Russia
  20. 8.4.10 Nordic Countries
9 China
  1. 9.1 China Chronic Gastritis Treatment Market Size (2021-2032)
  2. 9.2 China Chronic Gastritis Treatment Market Size by Type
  3. 9.2.1 China Chronic Gastritis Treatment Market Size by Type (2021-2026)
  4. 9.2.2 China Chronic Gastritis Treatment Market Size by Type (2027-2032)
  5. 9.2.3 China Chronic Gastritis Treatment Market Share by Type (2021-2032)
  6. 9.3 China Chronic Gastritis Treatment Market Size by Application
  7. 9.3.1 China Chronic Gastritis Treatment Market Size by Application (2021-2026)
  8. 9.3.2 China Chronic Gastritis Treatment Market Size by Application (2027-2032)
  9. 9.3.3 China Chronic Gastritis Treatment Market Share by Application (2021-2032)
10 Asia (Excluding China)
  1. 10.1 Asia Chronic Gastritis Treatment Market Size (2021-2032)
  2. 10.2 Asia Chronic Gastritis Treatment Market Size by Type
  3. 10.2.1 Asia Chronic Gastritis Treatment Market Size by Type (2021-2026)
  4. 10.2.2 Asia Chronic Gastritis Treatment Market Size by Type (2027-2032)
  5. 10.2.3 Asia Chronic Gastritis Treatment Market Share by Type (2021-2032)
  6. 10.3 Asia Chronic Gastritis Treatment Market Size by Application
  7. 10.3.1 Asia Chronic Gastritis Treatment Market Size by Application (2021-2026)
  8. 10.3.2 Asia Chronic Gastritis Treatment Market Size by Application (2027-2032)
  9. 10.3.3 Asia Chronic Gastritis Treatment Market Share by Application (2021-2032)
  10. 10.4 Asia Chronic Gastritis Treatment Market Size by Country
  11. 10.4.1 Asia Chronic Gastritis Treatment Market Size by Country (2021 VS 2025 VS 2032)
  12. 10.4.2 Asia Chronic Gastritis Treatment Market Size by Country (2021-2026)
  13. 10.4.3 Asia Chronic Gastritis Treatment Market Size by Country (2027-2032)
  14. 10.4.4 Asia Chronic Gastritis Treatment Market Share by Country (2021-2032)
  15. 10.4.5 Japan
  16. 10.4.6 South Korea
  17. 10.4.7 Taiwan
  18. 10.4.8 Southeast Asia
  19. 10.4.9 India
  20. 10.4.10 Australia
11 South America, Middle East & Africa
  1. 11.1 South America, Middle East & Africa Chronic Gastritis Treatment Market Size (2021-2032)
  2. 11.2 South America, Middle East & Africa Chronic Gastritis Treatment Market Size by Type
  3. 11.2.1 South America, Middle East & Africa Chronic Gastritis Treatment Market Size by Type (2021-2026)
  4. 11.2.2 South America, Middle East & Africa Chronic Gastritis Treatment Market Size by Type (2027-2032)
  5. 11.2.3 South America, Middle East & Africa Chronic Gastritis Treatment Market Share by Type (2021-2032)
  6. 11.3 South America, Middle East & Africa Chronic Gastritis Treatment Market Size by Application
  7. 11.3.1 South America, Middle East & Africa Chronic Gastritis Treatment Market Size by Application (2021-2026)
  8. 11.3.2 South America, Middle East & Africa Chronic Gastritis Treatment Market Size by Application (2027-2032)
  9. 11.3.3 South America, Middle East & Africa Chronic Gastritis Treatment Market Share by Application (2021-2032)
  10. 11.4 South America, Middle East & Africa Chronic Gastritis Treatment Market Size by Country
  11. 11.4.1 South America, Middle East & Africa Chronic Gastritis Treatment Market Size by Country (2021 VS 2025 VS 2032)
  12. 11.4.2 South America, Middle East & Africa Chronic Gastritis Treatment Market Size by Country (2021-2026)
  13. 11.4.3 South America, Middle East & Africa Chronic Gastritis Treatment Market Size by Country (2027-2032)
  14. 11.4.4 South America, Middle East & Africa Chronic Gastritis Treatment Market Share by Country (2021-2032)
  15. 11.4.5 Brazil
  16. 11.4.6 South Africa
  17. 11.4.7 Saudi Arabia
  18. 11.4.8 Turkey
  19. 11.4.9 Argentina
  20. 11.4.9 UAE
  21. 11.4.9 Egypt
  22. 11.4.9 Chile
12 Concluding Insights
    13 Appendix
    1. 13.1 Reasons for Doing This Study
    2. 13.2 Research Methodology
    3. 13.3 Research Process
    4. 13.4 Authors List of This Report
    5. 13.5 Data Source
    6. 13.5.1 Secondary Sources
    7. 13.5.2 Primary Sources
    8. 13.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst